Global Comparator Drug Sourcing Supply, Demand and Key Producers, 2026-2032
Description
The global Comparator Drug Sourcing market size is expected to reach $ 1980 million by 2032, rising at a market growth of 5.9% CAGR during the forecast period (2026-2032).
In clinical trials, comparator drugs are used to compare the efficacy of a drug in development to an existing treatment. The drugs might be a marketed therapy or a placebo, depending on the type of clinical trial. Comparator sourcing gives drug companies access to these drugs in large enough quantities. It does so quickly to ensure the smooth running of a clinical trial. It requires a robust supply chain, forecasting operations, and logistics expertise.
There has been a growing focus on comparative drug effectiveness in the global pharmaceutical industry. This is leading to pressure on pharmaceutical companies / sponsors to frame robust strategies for selection of a comparator drug, and then sourcing and maintaining an uninterrupted supply of that drug to all trial sites in a cost-effective manner. Direct comparator sourcing can be carried out by innovators / drug producers, wholesalers and local distributors. They follow either the central or local sourcing model depending on the study needs. Global key players of Comparator Drug Sourcing include Cencora, Thermo Fisher Scientific, Mckesson Corporation, Almac Group, Catalent, etc. The top five players hold a share about 77%. America is the largest market, and has a share about 40%, followed by Europe and APAC with share 31% and 26%, separately. In terms of product type, Local Sourcing is the largest segment, occupied for a share of 50%. In terms of application, Drug Producers/Manufacturers has a share about 46 percent.
This report studies the global Comparator Drug Sourcing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Comparator Drug Sourcing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Comparator Drug Sourcing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Comparator Drug Sourcing total market, 2021-2032, (USD Million)
Global Comparator Drug Sourcing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Comparator Drug Sourcing total market, key domestic companies, and share, (USD Million)
Global Comparator Drug Sourcing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Comparator Drug Sourcing total market by Type, CAGR, 2021-2032, (USD Million)
Global Comparator Drug Sourcing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Comparator Drug Sourcing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cencora, Thermo Fisher Scientific, Mckesson Corporation, Almac Group, Catalent, Sharp Services, LLC, Clinigen, Myonex, Oximio, Clinical Services International (CSI), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Comparator Drug Sourcing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Comparator Drug Sourcing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Comparator Drug Sourcing Market, Segmentation by Type:
Local Sourcing
Central Sourcing
Others
Global Comparator Drug Sourcing Market, Segmentation by Application:
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
Companies Profiled:
Cencora
Thermo Fisher Scientific
Mckesson Corporation
Almac Group
Catalent
Sharp Services, LLC
Clinigen
Myonex
Oximio
Clinical Services International (CSI)
ClientPharma
NewLife Medicals
Globyz Pharma
WuXi STA
Alliance Pharm
Inceptua
Key Questions Answered
1. How big is the global Comparator Drug Sourcing market?
2. What is the demand of the global Comparator Drug Sourcing market?
3. What is the year over year growth of the global Comparator Drug Sourcing market?
4. What is the total value of the global Comparator Drug Sourcing market?
5. Who are the Major Players in the global Comparator Drug Sourcing market?
6. What are the growth factors driving the market demand?
In clinical trials, comparator drugs are used to compare the efficacy of a drug in development to an existing treatment. The drugs might be a marketed therapy or a placebo, depending on the type of clinical trial. Comparator sourcing gives drug companies access to these drugs in large enough quantities. It does so quickly to ensure the smooth running of a clinical trial. It requires a robust supply chain, forecasting operations, and logistics expertise.
There has been a growing focus on comparative drug effectiveness in the global pharmaceutical industry. This is leading to pressure on pharmaceutical companies / sponsors to frame robust strategies for selection of a comparator drug, and then sourcing and maintaining an uninterrupted supply of that drug to all trial sites in a cost-effective manner. Direct comparator sourcing can be carried out by innovators / drug producers, wholesalers and local distributors. They follow either the central or local sourcing model depending on the study needs. Global key players of Comparator Drug Sourcing include Cencora, Thermo Fisher Scientific, Mckesson Corporation, Almac Group, Catalent, etc. The top five players hold a share about 77%. America is the largest market, and has a share about 40%, followed by Europe and APAC with share 31% and 26%, separately. In terms of product type, Local Sourcing is the largest segment, occupied for a share of 50%. In terms of application, Drug Producers/Manufacturers has a share about 46 percent.
This report studies the global Comparator Drug Sourcing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Comparator Drug Sourcing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Comparator Drug Sourcing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Comparator Drug Sourcing total market, 2021-2032, (USD Million)
Global Comparator Drug Sourcing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Comparator Drug Sourcing total market, key domestic companies, and share, (USD Million)
Global Comparator Drug Sourcing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Comparator Drug Sourcing total market by Type, CAGR, 2021-2032, (USD Million)
Global Comparator Drug Sourcing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Comparator Drug Sourcing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cencora, Thermo Fisher Scientific, Mckesson Corporation, Almac Group, Catalent, Sharp Services, LLC, Clinigen, Myonex, Oximio, Clinical Services International (CSI), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Comparator Drug Sourcing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Comparator Drug Sourcing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Comparator Drug Sourcing Market, Segmentation by Type:
Local Sourcing
Central Sourcing
Others
Global Comparator Drug Sourcing Market, Segmentation by Application:
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
Companies Profiled:
Cencora
Thermo Fisher Scientific
Mckesson Corporation
Almac Group
Catalent
Sharp Services, LLC
Clinigen
Myonex
Oximio
Clinical Services International (CSI)
ClientPharma
NewLife Medicals
Globyz Pharma
WuXi STA
Alliance Pharm
Inceptua
Key Questions Answered
1. How big is the global Comparator Drug Sourcing market?
2. What is the demand of the global Comparator Drug Sourcing market?
3. What is the year over year growth of the global Comparator Drug Sourcing market?
4. What is the total value of the global Comparator Drug Sourcing market?
5. Who are the Major Players in the global Comparator Drug Sourcing market?
6. What are the growth factors driving the market demand?
Table of Contents
134 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Comparator Drug Sourcing Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
